| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zevra Therapeutics, Inc. (ZVRA) has 11 insiders with recent SEC Form 4 filings, including 8 buys and 2 sells. ZVRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 222.0K | $2.47M | - | |
| CFO | 192.0K | $2.14M | - | |
| Dir | 84.2K | $936.3K | - | |
| Other | 48.1K | $535.1K | -1,794 | |
| Dir | 45.0K | $500.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Schafer Joshua52 | CCO &EVP, Bus. Development | Sell | 10,500 | $7.86 | $82,526.85 | -26.3% | +1.9% | +6.4% | |
| Feb 13, 2025 | Clifton R. Laduane55 | CFO &Treasurer | Sell | 11,000 | $7.86 | $86,471.00 | -17.6% | +1.9% | +6.4% | |
| Oct 11, 2024 | Watton Corey Michael46 | Director | Buy | 500 | $7.92 | $3,957.65 | +50.0% | -0.6% | +34.9% | |
| Jul 17, 2024 | Clifton R. Laduane55 | CFO &Treasurer | Buy | 2,000 | $6.77 | $13,540.00 | +12.1% | +27.2% | +92.1% | |
| Jul 16, 2024 | Anderson Thomas | Director | Buy | 10,000 | $6.81 | $68,065.00 | +100.0% | +23.5% | +88.4% | |
| Jul 12, 2024 | Bode John B66 | Director | Buy | 10,000 | $5.87 | $58,661.00 | +50.0% | +35.4% | +114.2% | |
| Sep 6, 2023 | Clifton R. Laduane55 | CFO, Secretary &Treasurer | Buy | 1,000 | $4.96 | $4,959.10 | +7.0% | +1.6% | +45.2% | |
| Sep 6, 2023 | Anderson Thomas | Director | Buy | 10,000 | $4.88 | $48,764.00 | New | +1.6% | +45.2% | |
| Sep 5, 2023 | Bode John B66 | Director | Buy | 10,000 | $5.13 | $51,333.00 | +100.0% | +0.8% | +42.9% | |
| Sep 5, 2023 | Schafer Joshua52 | CCO &EVP, Bus. Development | Buy | 500 | $5.13 | $2,564.50 | +16.7% | +0.8% | +42.9% |